Skip to main content
logo
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
46.44
+4.13 (9.76%)
Jul 28, 2026, 11:36 AM EDT - Market open

Eton Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
86.9379.9539.0131.6421.2521.83
Revenue Growth
79.89%104.94%23.29%48.90%-2.66%55879.49%
Gross Profit
47.6142.7423.4121.0614.3219.01
Operating Income
2.04-0.84-2.6-1.19-8.26-1.5
Net Income
-1.48-4.6-3.82-0.94-9.02-1.96
Earnings Per Share
-0.07-0.17-0.15-0.04-0.36-0.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.6625.9414.9421.3916.3114.41
Total Debt
31.1931.0229.925.46.526.7
Net Cash (Debt)
-11.53-5.08-14.9815.999.787.71
Net Cash Growth
---63.44%26.85%-45.52%
Net Cash Per Share
-0.40-0.19-0.580.620.390.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
15.8410.520.976.824.82-4.72
Capital Expenditures
--0.33-0.03--0.04-0.01
Free Cash Flow
15.8410.190.946.824.78-4.73
Free Cash Flow Growth
186.94%980.70%-86.16%42.48%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.77%53.46%60.01%66.56%67.38%87.05%
Operating Margin
2.35%-1.06%-6.66%-3.77%-38.87%-6.85%
Pretax Margin
-1.71%-5.70%-9.76%-2.18%-42.45%-8.95%
Profit Margin
-1.70%-5.75%-9.80%-2.96%-42.45%-8.95%
FCF Margin
18.22%12.75%2.42%21.54%22.51%-21.67%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
50.1330.5657.9179.6432.859.98
P/FCF Ratio
75.1144.88377.2716.5114.95-
PS Ratio
13.335.729.123.563.364.84